Summary
This prediction ended on 24.10.22 with a price of €0.64. The BUY prediction by BiotechBee for Tricida performed very badly with a performance of -93.82%. BiotechBee has 40% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Tricida | - | - | - |
iShares Core DAX® | 1.776% | 3.175% | 14.882% |
iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% |
iShares Nikkei 225® | -0.335% | 3.857% | 14.485% |
iShares S&P 500 | 0.854% | 2.567% | 31.105% |
According to BiotechBee what are the pros and cons of Tricida for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Tricida diskutieren
Buy mit Kursziel 25,0
In the thread Trading Tricida
Buy beendet